NHS Branded Medicines Tranche Framework for London and South of England
Estimated value
—
goods
Awarded value
—
Suppliers
39
9 SME
Lots
3
39 awarded
Published
20 Aug 2024
Total lots
3
Awarded
3
0 pending
Estimated total
£832.3m
Awarded total
—
Lot 1cancelled
CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South - Lot 1
Award value
—
Start
31 Aug 2024
End
31 Aug 2025
Estimated
£129.9m
CPV
33600000
Awarded to 16 suppliers
BI
Lot 2cancelled
CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South - Lot 2
Award value
—
Start
31 Aug 2024
End
31 Aug 2026
Estimated
£644.0m
CPV
33600000
Awarded to 20 suppliers
Lot 3cancelled
CM/PHR/22/5689/03 - Omalizumab and Diroximel Fumarate for MAE & NOFE - Lot 3
Award value
—
Start
31 Aug 2024
End
31 Aug 2025
Estimated
£58.3m
CPV
33600000
Awarded to 3 suppliers
BI